• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What can be expected from antimicrobial de-escalation in the critically ill?

作者信息

Kollef Marin H

机构信息

Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8052, St. Louis, MO, 63110, USA,

出版信息

Intensive Care Med. 2014 Jan;40(1):92-5. doi: 10.1007/s00134-013-3154-y. Epub 2013 Nov 19.

DOI:10.1007/s00134-013-3154-y
PMID:24248604
Abstract
摘要

相似文献

1
What can be expected from antimicrobial de-escalation in the critically ill?对于危重症患者的抗菌药物降阶梯治疗，我们可以期待什么？
Intensive Care Med. 2014 Jan;40(1):92-5. doi: 10.1007/s00134-013-3154-y. Epub 2013 Nov 19.
2
What's new in antimicrobial use and resistance in critically ill patients?危重症患者抗菌药物使用及耐药性方面有哪些新情况？
Intensive Care Med. 2014 Mar;40(3):422-6. doi: 10.1007/s00134-013-3190-7. Epub 2013 Dec 18.
3
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).危重症患者的抗菌药物降阶梯治疗：欧洲重症监护医学学会（ESICM）和欧洲临床微生物学和传染病学会（ESCMID）危重症患者研究小组（ESGCIP）的一个工作组的立场声明。
Intensive Care Med. 2020 Feb;46(2):245-265. doi: 10.1007/s00134-019-05866-w. Epub 2019 Nov 28.
4
[Antimicrobial therapy of severe infections in critically ill patients].[危重症患者严重感染的抗菌治疗]
Pol Merkur Lekarski. 2011 May;30(179):338-41.
5
Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.从实验台到病床的综述：旨在预防重症监护病房细菌耐药性产生的抗菌药物使用策略
Crit Care. 2005 Oct 5;9(5):459-64. doi: 10.1186/cc3757. Epub 2005 Jun 27.
6
How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.如何优化重症监护病房的抗菌药物处方：基于药代动力学和药效学的个体化给药原则。
Int J Antimicrob Agents. 2012 Mar;39(3):187-92. doi: 10.1016/j.ijantimicag.2011.11.002. Epub 2012 Jan 9.
7
An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients.抗菌药物管理计划可改善重症患者按培养部位进行的抗菌治疗以及抗菌药物处方质量。
Crit Care. 2012 Nov 5;16(6):R216. doi: 10.1186/cc11854.
8
Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?对于重症外科患者，呼吸机相关性肺炎抗生素治疗的降阶梯疗法是否会影响复发性肺炎的可能性或死亡率？
J Trauma. 2009 May;66(5):1343-8. doi: 10.1097/TA.0b013e31819dca4e.
9
Effective use of a clinical decision-support system to advance antimicrobial stewardship.有效利用临床决策支持系统推进抗菌药物管理。
Am J Health Syst Pharm. 2012 Sep 15;69(18):1543-4. doi: 10.2146/ajhp110729.
10
Antimicrobial Stewardship Approaches in the Intensive Care Unit.重症监护病房的抗菌药物管理方法
Infect Dis Clin North Am. 2017 Sep;31(3):513-534. doi: 10.1016/j.idc.2017.05.002. Epub 2017 Jul 5.

引用本文的文献

1
Focus on adequate antimicrobial treatment and de-escalation in the ICU.关注重症监护病房（ICU）中的充分抗菌治疗及降阶梯治疗。
Intensive Care Med. 2016 Dec;42(12):1856-1858. doi: 10.1007/s00134-016-4566-2. Epub 2016 Sep 29.
2
Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.医疗保健相关腹腔内感染期间抗感染降阶梯治疗的特征与结局
Crit Care. 2016 Apr 7;20:83. doi: 10.1186/s13054-016-1267-8.
3
"Does this patient have…" "Is this patient at risk for infection with multidrug resistant bacteria?".

本文引用的文献

1
Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes.生物标志物引导的经验性治疗降阶梯与不良结局风险较低相关。
Intensive Care Med. 2014 Jan;40(1):141. doi: 10.1007/s00134-013-3139-x. Epub 2013 Oct 30.
2
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.经验性治疗降级与严重脓毒症和感染性休克患者的死亡率降低相关。
Intensive Care Med. 2014 Jan;40(1):32-40. doi: 10.1007/s00134-013-3077-7. Epub 2013 Sep 12.
3
Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
“这位患者是否有……”“这位患者是否有感染多重耐药菌的风险？”
Intensive Care Med. 2017 Mar;43(3):436-439. doi: 10.1007/s00134-015-4126-1. Epub 2015 Nov 10.
4
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.在重症监护环境中，使用生物标志物与临床决策来决定抗生素的开始和停止时的利弊。
Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21.
5
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.《重症医学2014年年回顾：III. 严重感染、感染性休克、医疗相关感染、高度耐药菌、侵袭性真菌感染、严重病毒感染、埃博拉病毒病及儿科》
Intensive Care Med. 2015 Apr;41(4):575-88. doi: 10.1007/s00134-015-3755-8. Epub 2015 Mar 26.
6
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.针对携带高度耐药菌的重症患者的预防和治疗策略。
Intensive Care Med. 2015 May;41(5):776-95. doi: 10.1007/s00134-015-3719-z. Epub 2015 Mar 20.
7
Treatment of bloodstream infections in ICUs.重症监护病房血流感染的治疗
BMC Infect Dis. 2014 Nov 28;14:489. doi: 10.1186/1471-2334-14-489.
社区获得性和医疗相关性肺炎中耐药病原体的危险因素。
Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95. doi: 10.1164/rccm.201301-0079OC.
4
Progress on the development of rapid methods for antimicrobial susceptibility testing.抗菌药物敏感性快速检测方法的研发进展
J Antimicrob Chemother. 2013 Dec;68(12):2710-7. doi: 10.1093/jac/dkt253. Epub 2013 Jun 30.
5
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.评估急诊就诊肺炎患者中耐药病原体风险的临床评分的验证。
Clin Infect Dis. 2012 Jan 15;54(2):193-8. doi: 10.1093/cid/cir813. Epub 2011 Nov 21.
6
Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.革兰氏阴性菌败血症中不适当的抗生素治疗会增加住院时间。
Crit Care Med. 2011 Jan;39(1):46-51. doi: 10.1097/CCM.0b013e3181fa41a7.
7
Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study.严重脓毒症治疗的有效性：一项前瞻性、多中心、观察性研究。
Am J Respir Crit Care Med. 2009 Nov 1;180(9):861-6. doi: 10.1164/rccm.200812-1912OC. Epub 2009 Aug 20.
8
Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit.在重症监护病房中使用计算机决策支持系统减少广谱抗生素的使用
Int J Qual Health Care. 2006 Jun;18(3):224-31. doi: 10.1093/intqhc/mzi095. Epub 2006 Jan 13.
9
Strategies to prevent antimicrobial resistance in the intensive care unit.重症监护病房预防抗菌药物耐药性的策略。
Crit Care Med. 2005 Aug;33(8):1845-53. doi: 10.1097/01.ccm.0000171849.04952.79.
10
De-escalation therapy in ventilator-associated pneumonia.呼吸机相关性肺炎的降阶梯治疗
Crit Care Med. 2004 Nov;32(11):2183-90. doi: 10.1097/01.ccm.0000145997.10438.28.